Co-delivery of cisplatin and siRNA through hybrid nanocarrier platform for masking resistance to chemotherapy in lung cancer
Article in Drug Delivery and Translational Research (November 2020)
Lung Cancer:
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Molecular Pathology of Lung Cancer
-
Altmetric BadgeChapter 2 Tumor Microenvironment
-
Altmetric BadgeChapter 3 Racial and Ethnic Diversity in Lung Cancer
-
Altmetric BadgeChapter 4 Pharmacogenetics of Lung Cancer
-
Altmetric BadgeChapter 5 Lung Cancer Prevention
-
Altmetric BadgeChapter 6 Adjuvant and Neoadjuvant Therapy of NSCLC
-
Altmetric BadgeChapter 7 Chemoradiotherapy for Inoperable Non-small Cell Lung Cancer
-
Altmetric BadgeChapter 8 Management of Advanced Non-small Cell Lung Cancer: Front Line Treatment
-
Altmetric BadgeChapter 9 Chemotherapy in Previously Treated Patients with Non-small Cell Lung Cancer
-
Altmetric BadgeChapter 10 Epidermal Growth Factor Receptor Inhibitors in the Treatment of Non-small Cell Lung Cancer
-
Altmetric BadgeChapter 11 Angiogenesis Inhibitors in Lung Cancer
-
Altmetric BadgeChapter 12 Other Molecular Targeted Agents in Non-small Cell Lung Cancer
-
Altmetric BadgeChapter 13 Vaccine Therapy for Lung Cancer
-
Altmetric BadgeChapter 14 Gene-Based Therapies for Lung Cancer
-
Altmetric BadgeChapter 15 Lung Cancer Resistance to Chemotherapy
-
Altmetric BadgeChapter 16 Small Cell Carcinoma of the Lung
-
Altmetric BadgeChapter 17 Mesothelioma
-
Altmetric BadgeChapter 18 Advances in Oncology Clinical Research: Statistical and Study Design Methodologies
-
Altmetric BadgeChapter 19 Palliative Care for Patients with Lung Cancer
-
Altmetric BadgeChapter 20 The Future of Lung Cancer